One of NIH’s primary objectives is to strengthen the biomedical workforce. In order to provide greater support for the next generation of biomedical researchers, NIH has announced the Next Generation Researchers Initiative, whereby the agency is taking a multi-pronged approach that will both increase the number of early-stage and mid-career researchers and assist in stabilizing the trajectory of scientists. To carry out this initiative, NIH will:
- Commit approximately $210 million this year to this initiative. The funds will increase to about $1.1 billion dollars after five years to support promising early-stage and mid-career investigators
- Assess implementation effectiveness by creating an internal database and tracking the impact of NIH funding decisions for early- and mid-career investigators with fundable scores
- Emphasize more heavily the NIH funding mechanisms focused on early- and mid-career investigators
- Strive to fund most early-career investigators with R01 equivalent applications with scores in the top 25th percentile
- Encourage multiple approaches to develop and test metrics to evaluate the effectiveness of NIH’s research portfolio and assess the impact of NIH grant support on scientific progress
Applicants are not required to take any additional steps to be eligible for this funding consideration. At the start of this fiscal year, the NIH institute or center funding a grant will give applicants special consideration for support if they are: an early-stage investigator (10 years or less after completing your terminal degree/medical residency, have not received a substantial independent NIH research award, and received a score in the top 25th percentile) or a mid-career investigator (within 10 years of receiving first NIH R01 equivalent, scores in the 25th percentile, and are either at risk of losing all support or is a promising investigator supported by a single ongoing award.